详细目录 发表于 2025-3-30 09:59:56
Vitamin D and Its Role in CKD and CAD: A Novel Therapeutic Targetfect or a single surrogate marker. Randomized trials that examine cardiovascular and renal endpoints are urgently needed to provide the needed evidence to help guide future therapeutic strategies. This chapter considers the vitamin D hormonal system in the context of its regulation, deficiency, supp明智的人 发表于 2025-3-30 14:39:16
Association of Catalytic (Labile) Iron with Cardiovascular Morbidity and Mortalitye and diabetes. In asymptomatic hemodialysis patients, high catalytic iron identifies patients who have underlying coronary artery disease. Based on this collective data, clinical studies to evaluate the utility of catalytic iron for diagnosis and the potential benefit of iron chelators to prevent o膝盖 发表于 2025-3-30 19:51:35
Erythropoietin and Its Cardiovascular Effects the rate of Hb decline indicates the likelihood of the patient requiring a red blood cell (RBC) transfusion, and lowering the risk of alloimmunization and/or RBC transfusion risk is a goal. Interactions among various factors are responsible for an increased incidence of hypertension, left ventricul